Paid Alzheimer's Clinical Trials Near Me: What They Actually Cover and How to Vet a Site
What paid Alzheimer's and MCI clinical trials cover—stipends, no-cost PET scans, MRIs, p-tau217 blood tests—plus placebo rules and how to vet Phase 2/3 sites.
By Tokei Health, Cognitive Health Editorial Team
Draw the 11:10 clock on screen or upload a photo of a paper sheet — no signup required.
When families search for "paid Alzheimer's clinical trials near me," they are rarely looking for a side hustle. More often, they are trying to solve two urgent problems at once: getting high-level diagnostic answers without waiting nine months for a memory clinic, and exploring emerging treatments for Mild Cognitive Impairment (MCI) or early Alzheimer's disease without taking on crushing out-of-pocket costs.
Understanding how legitimate memory research studies actually work—what "paid" really means, what diagnostic testing is covered at no charge, how placebo arms work, and how to separate reputable Phase 2 and Phase 3 trials from misleading ads—helps you approach a research site with clarity and confidence.
What "Paid" Actually Means in Alzheimer's Clinical Trials
In everyday internet ads, the phrase "paid clinical trial" can sound like a paycheck. In regulated Alzheimer's and MCI research, Institutional Review Boards (IRBs) strictly regulate compensation so payments reimburse real-world burden without pressuring vulnerable families to ignore medical risks.
What you can realistically expect falls into two categories: direct stipends and no-cost clinical diagnostics.
| Benefit Category | Typical Structure in Phase 2 / Phase 3 Trials | What to Ask the Study Coordinator | | :--- | :--- | :--- | | Visit Stipends | Modest payment per completed clinic visit (often $50 to $150 per visit, sometimes higher for long imaging or infusion days) | "What is the exact stipend schedule, and is it paid via check, prepaid card, or direct deposit?" | | Travel & Meal Support | Parking validation, mileage reimbursement, rideshare vouchers, or hotel coverage for regional hubs | "Are rideshare or caregiver travel expenses reimbursed for both the participant and study partner?" | | Biomarker & Imaging Workup | No-cost blood biomarker panels (such as p-tau217), brain MRIs, and amyloid or tau PET scans during screening and follow-up | "Which screening scan or blood test results will be shared with us and our primary care doctor?" | | Specialist Monitoring | Regular exams with study neurologists, neuropsychologists, and research nurses at no cost to you or your insurer | "How do you communicate incidental MRI findings or safety alerts to our regular physician?" |
For many families, the no-cost diagnostic workup is far more valuable than the travel stipend. Outside a research setting, an amyloid PET scan, repeat brain MRIs, and multi-hour cognitive testing can require complex insurance pre-authorization or substantial copays. In a sponsored Phase 2 or Phase 3 trial, those study-required evaluations are covered by the trial sponsor.
Placebo vs. Active Treatment Arms: The Honest Trade-Off
One of the most important questions to ask before signing an informed consent form is how treatment assignment works.
- Randomized, Double-Blind Design: In most Phase 2 and Phase 3 studies, neither you nor the site doctor knows whether you are receiving the investigational drug or an inactive placebo. Allocation ratios vary—some trials use a 1:1 split (50% active, 50% placebo), while others use a 2:1 ratio favoring the active arm.
- Open-Label Extensions (OLE): Many late-stage Alzheimer's studies include an optional open-label extension phase after the main blinded period (often 12 to 24 months). During the extension, everyone who remains eligible can receive the active investigational therapy.
- Standard-of-Care Compatibility: Ask whether you must stay on a stable dose of existing memory medications (such as cholinesterase inhibitors) and whether certain blood thinners, psychiatric prescriptions, or prior anti-amyloid infusions affect eligibility. Never stop or change any prescribed medication to qualify for a trial without direct supervision from your prescribing clinician.
Important perspective: Joining a clinical trial is never a guarantee of medical improvement. Even active investigational drugs may prove ineffective or carry side effects—such as infusion reactions or MRI-monitored brain swelling/microbleeds (ARIA) in certain antibody trials. A trustworthy research team will walk through those risks plainly before you sign anything.
The Role of the Study Partner
Unlike a blood pressure or cholesterol study, almost every MCI and Alzheimer's clinical trial requires a study partner (sometimes called an informant or care partner). This is usually a spouse, adult child, sibling, or close friend who spends regular time with the participant—often at least several hours a week in person or by phone.
What a study partner actually does:
- Provides functional context: Completes structured interviews about everyday memory, bill-paying, appointments, mood, and independence that brief clinic quizzes can miss.
- Supports logistics and adherence: Helps track visit schedules, oral dosing or infusion appointments, and any new symptoms between visits.
- Receives their own support: Many trials include a separate stipend or travel reimbursement for the study partner's time, and some visits allow the study partner to participate by phone or video.
If an adult child lives in another city, ask the site early whether a remote study partner who speaks with the participant several times a week meets the protocol rules.
How to Vet a Legitimate Phase 2 or Phase 3 Trial on ClinicalTrials.gov
Social media recruitment ads often lead to third-party call centers that pre-screen patients for multiple local sites. That is not automatically a red flag, but you should always verify the underlying study yourself before sharing sensitive medical records.
A 5-Point Clinical Trial Safety Checklist
- Confirm the NCT Number: Every legitimate U.S. interventional trial has a unique identifier starting with
NCT(for example,NCT0...) listed on ClinicalTrials.gov. Look up the trial directly to read its sponsor, phase, inclusion criteria, and listed study locations. - Check the Phase and Purpose:
- Phase 1 focuses primarily on safety and dosing in small groups.
- Phase 2 evaluates early biological effect, dosing, and safety in a larger target population.
- Phase 3 compares effectiveness and safety against placebo or standard care across hundreds or thousands of participants before potential FDA review.
- Never Pay to Participate: Legitimate sponsored clinical trials do not charge enrollment fees, "concierge matching fees," or out-of-pocket fees for study-required drugs or scans.
- Verify IRB Oversight and Informed Consent: You should receive a multi-page Informed Consent Form (ICF) to take home, read with family, and discuss with your personal physician before consenting. You have the right to withdraw at any time for any reason.
- Look for Academic or Established Memory Research Centers: University Alzheimer's Disease Research Centers (ADRCs) and accredited neurology research clinics follow strict Good Clinical Practice (GCP) standards and have clear safety monitoring boards.
How to Prepare a Baseline Before Contacting a Research Site
When you call a clinical trial site, the intake coordinator will typically ask a short set of screening questions: age, current medications, whether a study partner is available, whether a doctor has mentioned MCI or Alzheimer's, and what specific memory or thinking changes have been noticed over the past 6 to 12 months.
Arriving prepared makes that first conversation far more productive:
- Write down 4–5 concrete, dated examples of recent memory or planning changes (for instance, repeating questions within the same hour, misplacing bills, or getting turned around on a familiar route).
- Gather your medication and medical history list, including any prior brain MRI reports, blood work, or cognitive screening scores. If you already have a score from a clinic visit, you can review what common screening ranges mean using our Cognitive Score Interpreter.
- Document an objective home baseline: Taking a quick, standardized Clock Drawing Test online or printing our Printable Clock Drawing Test gives you a dated, visual snapshot of visuospatial planning and executive function to bring to your doctor or discuss during pre-screening.
Educational note: Tokei Health (Coadia, Inc.) provides educational cognitive self-check software and plain-English guides—not medical advice, clinical diagnosis, or healthcare services. Always review clinical trial eligibility and medical decisions with a qualified physician.
Frequently Asked Questions
- Do Alzheimer's clinical trials actually pay participants?
- Most legitimate Phase 2 and Phase 3 Alzheimer's or Mild Cognitive Impairment (MCI) trials provide modest visit stipends—typically covering travel, parking, meals, and time—rather than a large salary. The larger financial value is usually no-cost access to specialist memory exams, brain MRIs, amyloid PET scans, and blood biomarker tests.
- Will I or my parent definitely receive the active study drug?
- Usually not right away. Most Phase 2 and Phase 3 studies randomize participants to either the investigational therapy or a placebo so researchers can measure real benefit and safety. Many modern trials include an open-label extension after the blinded phase where all eligible participants can receive the active medication.
- Why do Alzheimer's clinical trials require a study partner?
- A study partner—usually a spouse, adult child, or close friend who sees or speaks with the participant regularly—provides structured feedback on everyday memory, mood, and independence. Study partners also help coordinate visits and watch for side effects.
- Can I join an Alzheimer's clinical trial without an official diagnosis?
- Some prevention trials enroll cognitively healthy adults with elevated Alzheimer's biomarkers, while MCI and early Alzheimer's trials screen for subtle memory changes during intake. Most sites will evaluate eligibility themselves at no cost during the screening phase.
- How can I tell if a local Alzheimer's trial site is legitimate?
- Verify the study's NCT identifier on ClinicalTrials.gov, confirm Institutional Review Board (IRB) oversight and written informed consent, ensure you are never asked to pay to enroll, and check that a board-certified neurologist or geriatrician oversees the research team.
Take a 3-Minute Cognitive Baseline & Check Study Eligibility
Start with our free 3-minute clock & delayed recall screen, check reversible medication and sleep contributors, and optionally match with enrolling MCI and Alzheimer's studies near your ZIP code.
Free 3-minute clock check · No account required
Educational self-check software: Tokei Health (Coadia, Inc.) is not a healthcare provider and does not offer medical services, diagnosis, or medical advice. Always consult a qualified physician or pharmacist before making any health or medication decisions.